The Effect of Golden Sea cucumber (Stichopus hermanii) and Hyperbaric Oxygen Therapy to The Expression of Osteoprotegerin in Diabetes Mellitus Induce by Porphyromonas gingivalis Bacteria

Authors

  • Luthvina Setiami Aziza Undergraduate Faculty of Dentistry Hang Tuah University Surabaya
  • Kristanti Parisihni Biologi oral Fakultas Kedokteran Gigi Universitas Hang Tuah
  • Dian Mulawarmanti Biologi oral Fakultas Kedokteran Gigi Universitas Hang Tuah

Keywords:

Diabetes Melitus, Periodontitis, Alveolar Bone Resorption, Osteoprotegerin, Immunohistochemical, Stichopus hermanii, hyperbaric Oxygen .

Abstract

Background: Diabetes mellitus (DM) with Periodontitis cause severe  alveolar bone resorption. Osteoprotegerin prevent osteoclastogenesis process so that inhibited alveolar bone resorption. Stichopus hermanii powder and hyperbaric oxygen therapy (HBO) have  content  and good effects in wound healing. Purpose: The aim of this reseach was to analyze the effect of Stichopus hermanii powder and HBO therapy  in  the increasing of osteoprotegerin expression on DM with periodontitis. Materials and Methods: The research was an experimental laboratories post test only control group design.  Twenty  Wistar rats were divided into 5 groups. K0 was negative group while  K1 was positive group K1-K4 groups were induced with 65mm/kg STZ single dose and 2ml bacterium P. gingivalis., K2 was treated with 3%golden sea cucumber powder in gel form. K3 was treated with OHB therapy 2.4 ATA for 7 days and K4 given a combination of both. Osteoprotegrin expression on osteoblast of alveolar mandible bone were examined by immunohistochemical staining. Data were analyzed by Kruskal-Wallis and Mann-Whitney test. Result: Kruskal-Wallis result showed significant differences from each treatment group (p <0.05). Mann-Whitney test showed the decreasion in the expression of osteoprotegerin between K1(2:50 ± 0.577) compare with K0 (p<0.05). Golden sea cucumber powder, HBO therapy and both combination had  increased osteoprotegerin expression.significancy in K2(8.25 ± 1.258), K3 (5.75 ± 0.957) and K4(12.50 ± 2.082) (p<0,05). Conclusion: Stichopus hermanii powder 3% and 2.4 ATA OHB therapy for 7 days increased  the expression osteoprotegrin on DM with periodontitis.

Downloads

Download data is not yet available.

References

Nandya, Erna Manduratna dan Agustina EF. Status Kesehatan Jaringan Periodontal Pada Pasien Diabetes Mellitus Tipe 2 Dibandingkan Dengan Pasien Non Diabetes Mellitus Berdasarkan GPI; 2011. P.2 Available at http://journal.unair.ac.id/filerPDF/e-Journal%20Status%20kesehatan%20jaringan%20periodontal.pdf.

Zhang W, Ju J, Rigney T, Tribble G. Porphyromonas gingivalis Infection Increases Osteoclastic Bone Resorption and Osteoblastic Bone Formation in a Periodontitis Mouse Model. BMC Oral Health 2014; 14(89): 9-1.

Lely SMA, Indirawati T. Pengaruh Kadar Glukosa Darah Terkontrol Terhadap Penurunan Derajat Kegoyangan Gigi Penderita Diabetes Melitus di RS Persahabatan Jakarta. Media Litbang Jakarta 2004; 14(3): 44-37.

Pacios S, Andriankaja O, Kang J, Alnammary M, Bae J, Bazerra BB, Scheiner H, Fine DH, Graves DT. Bacterial Infection Increases Periodontal Bone Loss in Diabetic Rats Through Enhanced Apoptosis. The American Journal of Pathology 2013; 183(6): 1935-1929.

Maeley BL & Oates TW. Diabetes Mellitus and Periodontal Disease. Department of Peridontics University of Texas Health Science Center. J Periodontol 2006; 8: 1289-303.

Kesic L, Milasin J, Igic M and Obradovic R. Microbial Etiology of Periodontal Disease–Mini Review. Medicine and Biology 2008; 15(1): 6-1.

Graves D. 2008. Cytokines that Promote Periodontal Tissue Destruction. Journals of Periodontology, 79(8): 1591-1585.

Anil S, Varma V, Preethanath RS, Anand & Al Farraj A. 2012. The Emerging Concepts on The Impact of Periodontitis on Systemic Health. Periodontal Disease-A Clinician’s Guide; 2012. P. 149 Available from: http://www.intechopen.com/download/pdf/27460.

Schulze A & Busse M. Periodontal Disease in Diabetics : Relationship, Prevention, and Treatment. General Outpatient Ambulance and Dental Ambulance of the Institute of Sportsmedicine, University of Leipzig. CSMI 2008; 1(2): 4-1.

Morran MP, Alexander LA, Slotterbeck BD, Mclnerney MF. Dysfunctional Innate I Immune Responsiveness to Porphyromonas Gingivalis Lipopolysaccharide in Diabetes. Oral Microbiology Immunology 2009; 24: 339-331.

Signoretto C, Bianchi F, Bianchi F, Burlacchini, Canepari P. Microbiological Evaluation of The Effects of Hyperbaric Oxygen Periodontal Disease. Dipartimento di Patologia, Sezione di Microbiologia Universita di Verona Italia. New Microbiol 2007; 30(4): 437-431.

Ratnawati A, Izak DR, Supardi A. Sintesis dan Karakterisasi Kolagen dari Teripang-Kitosan sebagai Aplikasi Pembalut Luka; 2011. P. 5. Available at http://journal.unair.ac.id/filerPDF/jurnal%20AyuRatnawati.pdf.

Bordbar S, Anwar F, Saari N. High-Value Components and Bioactives from Sea Cucumbers for Functional Foods-A Review. Marine Drgs 2011; 9: 1805-761.

Tat SK, Pelletier JP, Verges J, Lajeunesse D, Montelle E, Fahmi H, Lavigne M, Pelletier JM. Chondroitin and Glucosamine Sulfate in Combination Decrease the Pro-Resorptive Properties of Human Osteoarthritis Subchondral Bone Osteoblasts: A Basic Science Study. Arthritis Research & Therapy 2007; 9(6): 10-1.

Muttaqien W. Daya Hambat Teripang emas (stichopus hermanii) Terhadap Pertumbuhan Bakteri Mixed Periodontal. Fakultas Kedokteran Gigi Universitas Hang Tuah Surabaya. Indonesia; 2011. Hlm. 25-24.

Bhutani S and Vishwanath G. Hyperbaric Oxygen and Wound Healing. Indian Journal of Plastic Surgary 2012; 45(2): 324-316.

Jain N, Deepa D. Applications of Hyperbaric Oxygen Therapy in Dentistry: A Mini Review. Journals of Interdiciplinary Dentistry 2014; 4: 32-27.

Al Hadi H, Smerdon GR, Fox SW. Hyperbaric Oxygen Therapy Suppresses Osteoclast Formation and Bone Resorption. Journals of Orthopedi Research 2013; 1844-1839.

Cochran, DL. Inflammation and Bone Loss in Periodontal Disease. Journals of Periodontal Online 2008; 79(8): 1576-1569.

Kearns AE, Kholas S, Kostenuik PJ. Receptor Activator of Nuclear Factor B Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease. Endocrine Reviews 2008; 29(2): 192-155.

Koide M, Kobayashi Y, Ninomiya T, Nakamura M, Yasuda H, Arai Y, Okahashi N, Yoshinari N, Takahashi N, Udagawa N. Osteoprotegerin-Deficient Male Mice as a Model for Severe Alveolar Bone Loss: Comparison With RANKLOverexpressing Transgenic Male Mice. Endocrinology 2013; 154(2): 782-773.

Hienz SA, Paliwal S, Ivanoski S. Mechanisms of Bone Resorption in Periodontitis. Journals Immunology Research.; 2014. P. 10-1.

Mulawarmanti D & Widyastuti. Effect of Hyperbaric Oxygen Therapy on Malondialdehyde Levels in Saliva of Periodontitis Patients with Type 2 Diabetes Mellitus. Dental Journal Majalah Kedokteran Gigi 2008; 41(4): 39-30.

Srinivasan K , Ramarao P. 2007. Animal Models in Type 2 Diabetes Research: An Overview. Indiana Journals Medical Research 2007; 125: 472-451.

Kesavalu L, Sathishkumar S, Bakthavatchalu V, Matthews C, Dawson D, Steffen M, Ebersole JL. Rat Model of Polymicrobial Infection, Immunity, and Alveolar Bone Resorption in Periodontal Disease. Infection and Immunity 2007; 75(4): 1712-1704.

Praptiwi. 2008. Inokulasi Bakteri dan Pemasangan Cincin Ligatur untuk Induksi Periodontitis pada Tikus. Majalah Kedokteran Gigi 2008; 15(1): 84-81.

Prabowo S, Nataatmadja M, Hadi JP, Dikman I, Handajani F, Tehupuring SEJ, Soetarso I, Suryokusumo MG, Aulanni’am A, Herawati A, West M. Hyperbaric Oxygen Treatment in a Diabetic Rat Model is Associated with a Decrease in Blood Glukose, Regression of Organ Demage and Improvement in Wound Healing. Scientific Research Health 2014; 6: 1958-1950.

Sharp T, Saunder G. Methode of Euthanasia; 2004. P. 5. Available at http://www.shellharbour.nsw.gov.au./filedata/pdf/methodeofeuthanasia.pdf.

Yulvie W. Evaluasi Ekspresi RANKL Dan OPG Pada Ameloblastoma Tipe Folikular, Tipe Fleksiform, Dan Tipe Campuran. Tesis Fakultas Kedokteran Gigi Program Studi Bedah Mulut Dan Maksilofasial; 2012. Hlm. 22-1.

Claudino M, Gennaro G, Cestari TM, Spadella CT, Garlet GP, Assis GF. Spontaneous Periodontitis Development in Diabetic Rats Involves an Unrestricted Expression of Inflammatory Cytokines and Tissue Destructive Factors in the Absence of Major Changes in Commensal Oral Microbiota. Experimental Diabetes Research; 2012. P. 10-1.

Malik G, Lehl G, Talwar M. Association Of Periodontitis With Diabetes Mellitus: A Review. Journal of Medical 2011; 1(1): 14-10.

Nugroho AE. Review Hewan Percobaan Diabetes Mellitus : Patologi dan Mekanisme Aksi Diabetogenik. Laboratorium Farmakologi dan Toksikologi, Fakultas Farmasi Universitas Gadjah Mada. Biodiversitas 2006; 7(4): 382-378.

Golz L, Memmert S, Rath-Deschner B, Joger A, Appel T, Baumgarten G, Gotz W, Frede S. LPS from P. gingivalis and Hypoxia Increases Oxidative Stress in Periodontal Ligament Fibroblasts and Contributes to Periodontitis. Research Artikel Hindawi; 2014. P. 13-1.

Preshaw PM, Alba L, Herrera D, Jepsen S, Konstantinidis A, Makrilakis K, Taylor R. Periodontitis and Diabetes : a Two-Way Relationship. Diabetologi 2012; 55(1): 31-21.

Bahrami Y, Zhang W, Chataway T, and Franco C. Structural Elucidation of Novel Saponins in the Sea Cucumber Holothuria lesson. Mar. Drugs 2014; 12(8): 4473-4439.

Nair MP, Mahajan S, Reynolds JL, Aalinkel R, Nair H, Schwartz SA and Kandaswami C. The Flavonoid Quercetin Inhibits Proinflammatory Cytokine (Tumor Necrosis Factor Alpha) Gene Expression in Normal Peripheral Blood Mononuclear Cells via Modulation of the NF-kB System. Clinical and Vaccine Immunology 2006; 13(3): 321-319.

Trzeciakiewicz A, Habauzit V and Hurcajada MN. When Nutrition Interacts with Osteoblast Function: Molekuler Mechanism of Polyphenols. Nutrition Research Review 2009; 22: 77.

Kveiborg M, Flyvbjerg A, Eriksen EF, Kassem M. Transforming Growth Factor-1 Stimulates the Production of Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3 in Human Bone Marrow Stromal Osteoblast Progenitors. Journal of Endocrinology 2001; 169: 549-61.

Thomas GP, Baker SUK, Eisman JA, Gardiner EM. Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts. Journals of Endocrinology 2001; 170: 460-451.

Lovu M, Dumais G and Du Souich P. Anti-inflammatory activity of chondroitin sulfate. International. Cartilage Repair Society 2008; 16: 18-14.

Harnanik T. Efek Oksigenasi Hiperbarik Terhadap Peningkatan Aktivitas Antioksidan pada Penderita Diabetes Mellitus Tipe 2. Tesis. Surabaya: Program Pasca Sarjana. Universitas Airlangga; 2008. Hlm. 89-87.

Thom SR. Oxidative Stress in Fundamental to Hyperbaric Oxygen Therapy. J Appl Physiol 2009; 106: 995-988.

Huda N. Pengaruh Hiperbarik Oksigen Teradap Perfusi Perifer Luka Gangren pada Penderita DM di RSAL Dr.Ramelan Surabaya. Tesis. Fakultas Ilmu keperawatan Universitas Indonesia; 2010. Hlm. 106-103.

Al Hadi HW. The effect of Hyperbaric Oxygen Therapy on Osteoclast and Osteoblast Function. Thesis Faculty of Science and Technology; 2013. P. 130-13.

Downloads

Published

2021-09-14

How to Cite

Luthvina Setiami Aziza, Kristanti Parisihni, & Dian Mulawarmanti. (2021). The Effect of Golden Sea cucumber (Stichopus hermanii) and Hyperbaric Oxygen Therapy to The Expression of Osteoprotegerin in Diabetes Mellitus Induce by Porphyromonas gingivalis Bacteria. DENTA JURNAL KEDOKTERAN GIGI, 10(2), 165–174. Retrieved from https://journal-denta.hangtuah.ac.id/index.php/jurnal/article/view/138

Issue

Vol. 10 No. 2 (2016): Agustus

Section

Articles

License

Copyright (c) 2016 Universitas Hang Tuah

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Dengan menggunakan Hak Lisensi (sebagaimana didefinisikan di bawah), Anda menerima dan setuju untuk terikat oleh syarat dan ketentuan Lisensi Publik Internasional Creative Commons Atribusi-BerbagiSerupa 4.0 ini ("Lisensi Publik"). Sejauh Lisensi Publik ini dapat diartikan sebagai suatu kontrak, Anda diberikan Hak Lisensi dengan mempertimbangkan penerimaan Anda terhadap syarat dan ketentuan ini, dan Pemberi Lisensi memberikan Anda hak tersebut dengan mempertimbangkan manfaat yang diterima Pemberi Lisensi dari penyediaan Materi Berlisensi berdasarkan syarat dan ketentuan ini.

Bagian 1 – Definisi.

  1. Materi Adaptasi  berarti materi yang tunduk pada Hak Cipta dan Hak Serupa yang berasal dari atau berdasarkan Materi Berlisensi dan di mana Materi Berlisensi tersebut diterjemahkan, diubah, disusun, ditransformasi, atau dimodifikasi dengan cara lain yang memerlukan izin berdasarkan Hak Cipta dan Hak Serupa yang dimiliki oleh Pemberi Lisensi. Untuk tujuan Lisensi Publik ini, jika Materi Berlisensi berupa karya musik, pertunjukan, atau rekaman suara, Materi Adaptasi selalu diproduksi di mana Materi Berlisensi tersebut disinkronkan dalam hubungan waktu dengan gambar bergerak.
  2. Lisensi Adaptor  berarti lisensi yang Anda terapkan pada Hak Cipta dan Hak Serupa dalam kontribusi Anda pada Materi Adaptasi sesuai dengan syarat dan ketentuan Lisensi Publik ini.
  3. Lisensi Kompatibel BY-SA  berarti lisensi yang tercantum di  creativecommons.org/compatiblelicenses , yang disetujui oleh Creative Commons sebagai padanan hakiki dari Lisensi Publik ini.
  4. Hak Cipta dan Hak Serupa  berarti hak cipta dan/atau hak serupa yang berkaitan erat dengan hak cipta, termasuk, namun tidak terbatas pada, hak pertunjukan, hak siaran, hak rekaman suara, dan Hak Basis Data Sui Generis, tanpa memperhatikan bagaimana hak tersebut diberi label atau dikategorikan. Untuk tujuan Lisensi Publik ini, hak-hak yang disebutkan dalam Pasal  2(b)(1)-(2)  bukan merupakan Hak Cipta dan Hak Serupa.
  5. Langkah-Langkah Teknologi yang Efektif  berarti langkah-langkah yang, jika tidak ada kewenangan yang tepat, tidak dapat dielakkan berdasarkan hukum yang memenuhi kewajiban berdasarkan Pasal 11 Perjanjian Hak Cipta WIPO yang diadopsi pada tanggal 20 Desember 1996, dan/atau perjanjian internasional serupa.
  6. Pengecualian dan Batasan  berarti penggunaan wajar, perlakuan wajar, dan/atau pengecualian atau batasan lain terhadap Hak Cipta dan Hak Serupa yang berlaku untuk penggunaan Anda atas Materi Berlisensi.
  7. Elemen Lisensi  berarti atribut lisensi yang tercantum dalam nama Lisensi Publik Creative Commons. Elemen Lisensi dari Lisensi Publik ini adalah Atribusi dan Berbagi Serupa.
  8. Materi Berlisensi  berarti karya seni atau sastra, basis data, atau materi lain yang kepadanya Pemberi Lisensi menerapkan Lisensi Publik ini.
  9. Hak Berlisensi  berarti hak yang diberikan kepada Anda sesuai dengan syarat dan ketentuan Lisensi Publik ini, yang terbatas pada semua Hak Cipta dan Hak Serupa yang berlaku untuk penggunaan Anda atas Materi Berlisensi dan yang Pemberi Lisensi berwenang untuk melisensikannya.
  10. Pemberi lisensi  berarti individu atau badan yang memberikan hak berdasarkan Lisensi Publik ini.
  11. Berbagi  berarti menyediakan materi kepada publik melalui cara atau proses apa pun yang memerlukan izin berdasarkan Hak Lisensi, seperti reproduksi, tampilan publik, pertunjukan publik, distribusi, penyebaran, komunikasi, atau impor, dan menyediakan materi kepada publik termasuk dengan cara yang memungkinkan anggota publik mengakses materi tersebut dari suatu tempat dan pada waktu yang mereka pilih sendiri.
  12. Hak Basis Data Sui Generis  berarti hak-hak selain hak cipta yang timbul dari Direktif 96/9/EC Parlemen Eropa dan Dewan tanggal 11 Maret 1996 tentang perlindungan hukum basis data, sebagaimana telah diubah dan/atau digantikan, serta hak-hak lain yang pada hakikatnya setara di mana pun di dunia.
  13. Anda  berarti individu atau entitas yang menjalankan Hak Lisensi berdasarkan Lisensi Publik ini.  "Anda"  memiliki arti yang sesuai.

Bagian 2 – Ruang Lingkup.

  1. Pemberian lisensi .
    1. Tunduk pada syarat dan ketentuan Lisensi Publik ini, Pemberi Lisensi dengan ini memberikan Anda lisensi yang berlaku di seluruh dunia, bebas royalti, tidak dapat disublisensikan, tidak eksklusif, dan tidak dapat dibatalkan untuk melaksanakan Hak Lisensi dalam Materi Berlisensi untuk:
      1. memperbanyak dan Membagikan Materi Berlisensi, secara keseluruhan atau sebagian; dan
      2. memproduksi, memperbanyak, dan Berbagi Materi yang Diadaptasi.
    2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.
    3. Term. The term of this Public License is specified in Section 6(a).
    4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a)(4) never produces Adapted Material.
    5. Downstream recipients.
      1. Offer from the Licensor – Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.
      2. Additional offer from the Licensor – Adapted Material. Every recipient of Adapted Material from You automatically receives an offer from the Licensor to exercise the Licensed Rights in the Adapted Material under the conditions of the Adapter’s License You apply.
      3. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.
    6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).

  2. Other rights.

    1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.
    2. Patent and trademark rights are not licensed under this Public License.
    3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties.

Section 3 – License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

  1. Attribution.

    1. If You Share the Licensed Material (including in modified form), You must:

      1. retain the following if it is supplied by the Licensor with the Licensed Material:
        1. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);
        2. a copyright notice;
        3. a notice that refers to this Public License;
        4. a notice that refers to the disclaimer of warranties;
        5. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;
      2. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and
      3. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.
    2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.
    3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.
  2. ShareAlike.

    In addition to the conditions in Section 3(a), if You Share Adapted Material You produce, the following conditions also apply.

    1. The Adapter’s License You apply must be a Creative Commons license with the same License Elements, this version or later, or a BY-SA Compatible License.
    2. You must include the text of, or the URI or hyperlink to, the Adapter's License You apply. You may satisfy this condition in any reasonable manner based on the medium, means, and context in which You Share Adapted Material.
    3. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, Adapted Material that restrict exercise of the rights granted under the Adapter's License You apply.

Section 4 – Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

  1. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database;
  2. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material, including for purposes of Section 3(b); and
  3. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.

For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 – Disclaimer of Warranties and Limitation of Liability.

  1. Unless otherwise separately undertaken by the Licensor, to the extent possible, the Licensor offers the Licensed Material as-is and as-available, and makes no representations or warranties of any kind concerning the Licensed Material, whether express, implied, statutory, or other. This includes, without limitation, warranties of title, merchantability, fitness for a particular purpose, non-infringement, absence of latent or other defects, accuracy, or the presence or absence of errors, whether or not known or discoverable. Where disclaimers of warranties are not allowed in full or in part, this disclaimer may not apply to You.
  2. To the extent possible, in no event will the Licensor be liable to You on any legal theory (including, without limitation, negligence) or otherwise for any direct, special, indirect, incidental, consequential, punitive, exemplary, or other losses, costs, expenses, or damages arising out of this Public License or use of the Licensed Material, even if the Licensor has been advised of the possibility of such losses, costs, expenses, or damages. Where a limitation of liability is not allowed in full or in part, this limitation may not apply to You.
  1. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 – Term and Termination.

  1. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

  2. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

    1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or
    2. upon express reinstatement by the Licensor.
    For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.
  3. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.
  4. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Bagian 7 – Syarat dan Ketentuan Lainnya.

  1. Pemberi Lisensi tidak akan terikat oleh ketentuan atau persyaratan tambahan atau berbeda yang dikomunikasikan oleh Anda kecuali disetujui secara tegas.
  2. Segala pengaturan, kesepahaman, atau perjanjian mengenai Materi Berlisensi yang tidak dinyatakan di sini terpisah dari dan independen dari syarat dan ketentuan Lisensi Publik ini.

Bagian 8 – Interpretasi.

  1. Untuk menghindari keraguan, Lisensi Publik ini tidak, dan tidak akan ditafsirkan untuk, mengurangi, membatasi, mengekang, atau memaksakan ketentuan pada penggunaan Materi Berlisensi yang secara sah dapat dilakukan tanpa izin berdasarkan Lisensi Publik ini.
  2. Sedapat mungkin, jika ada ketentuan dalam Lisensi Publik ini yang dianggap tidak dapat diberlakukan, ketentuan tersebut akan secara otomatis direformasi hingga batas minimum yang diperlukan agar dapat diberlakukan. Jika ketentuan tersebut tidak dapat direformasi, ketentuan tersebut akan dihapus dari Lisensi Publik ini tanpa memengaruhi keberlakuan syarat dan ketentuan lainnya.
  3. Tidak ada syarat atau ketentuan Lisensi Publik ini yang akan diabaikan dan tidak ada kegagalan untuk mematuhi yang disetujui kecuali disetujui secara tegas oleh Pemberi Lisensi.
  4. Tidak ada satu pun dalam Lisensi Publik ini yang merupakan atau boleh ditafsirkan sebagai pembatasan atau pengesampingan hak istimewa dan kekebalan apa pun yang berlaku bagi Pemberi Lisensi atau Anda, termasuk dari proses hukum di yurisdiksi atau otoritas mana pun.

Most read articles by the same author(s)